surfactant protein C; propeptide targeting; A549 cells; green fluorescent protein THE ALVEOLAR TYPE II CELL is a specialized epithelial cell responsible for the synthesis and secretion of pulmonary surfactant, a complex mixture of phospholipids and proteins required for the maintenance of alveolar stability at low lung volumes (end expiration) (25) . In addition to phospholipids, organic extracts of isolated surfactant proteins (SPs) have been shown to contain two small hydrophobic proteins, SP-B and SP-C, which, alone or in combination, confer properties of rapid surface absorption and lowering of surface tension to reconstituted synthetic lipids (23, 30) . The importance of SP-C to surfactant function is underscored by experiments in which the administration of a synthetic surfactant containing recombinant SP-C as the sole protein component to preterm animals produced biophysical properties similar to natural bovine surfactant (10) . Recently, lethal SP-C deficiency in human infants has also been described (31) .
The lipid and protein components of surfactants are stored in special secretory organelles, lamellar bodies, which are released by regulated exocytosis in response to secretagogue stimulation (24, 26) . The secretory pathway of the type II cell is atypical, in that protein and lipid surfactant components have been shown to be endocytosed and routed back to lamellar bodies (3, 28) . Lamellar bodies are partially lysosomal in nature, in that they have been shown to contain lysosomal acid hydrolases and to possess the lysosomal glycoprotein marker CD63 as well as the integral lysosomal membrane protein LAMP-1 (26, 32) .
Rat SP-C is synthesized by the alveolar type II cell as a proprotein of 194 amino acids (6, 12) . Contained within the propeptide is the 35-amino acid residue mature SP-C protein (SP-C 3.7 ), which is flanked by propeptides of 23 amino acids at the NH 2 terminus and 136 residues at the COOH terminus. Unlike other SPs, the NH 2 terminus of the primary translation product does not contain a cleavable signal sequence, there are no sites for asparagine-linked glycosylation (6) , and the mature SP-C molecule is an integral membrane protein. Nonetheless, after translation, proSP-C must be translocated to the endoplasmic reticulum (ER) membrane and routed into the distal secretory compartments, where it has been shown to undergo proteolysis, leading to production of the 3.7-kDa alveolar form. Therefore, the SP-C molecule is unique, in that the primary translation product represents a bitopic, transmembrane protein (18) that is ultimately secreted via the regulated exocytic pathway of epithelial cells as a processed, extremely lipophilic, mature peptide.
In vitro and in vivo models have been used to partially characterize the processing events that lead to the production of SP-C in alveolar surfactant. Pulsechase experiments in isolated type II cells have demonstrated processing of proSP-C 21 to 16-and 6-kDa intermediate forms, which involves an initial two-step removal of the COOH-terminal domains followed by the cleavage of the NH 2 -terminal domains (7, 29) . Posttranslational proteolysis can be blocked by the use of brefeldin A (7), by low-temperature incubation (20°C) (29) , or by inhibitors of organellar acidification (methylamine, bafilomycin A 1 ) (4), which indicates that proteolysis is occurring within acidic subcellular compartments in the distal secretory pathway.
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Relatively little is known of the role of specific peptide domains contained within the proSP-C sequence that influence posttranslational subcellular targeting and processing. Recently, our laboratory has evaluated the role of the COOH terminus of proSP-C in intracellular processing of the primary translation product (8) . Synthesis and processing of SP-C were evaluated using a lung epithelial cell line (A549) transfected with the eukaryotic expression vector containing the full-length cDNA or one of several COOH-terminal truncated forms. In these cells, immunoprecipitation of 35 S-labeled cell lysates demonstrated synthesis and processing of proSP-C 21 through the SP-C 16 and SP-C 6 intermediates by cleavages of the COOH-terminal propeptide. The wild-type SP-C protein was targeted to cytoplasmic vesicles of A549 cells. In contrast, deletion of as few as 10 amino acids from the COOH terminus resulted in translation but no further processing of mutant proteins. Double-label fluorescence immunocytochemistry with fluorescein isothiocyanate-concanavalin A indicated restriction of COOH-terminal mutants to an ER/Golgi compartment, demonstrating an association between targeting and subsequent processing.
The present study further extends the findings of the previous studies (4, 7, 8, 29) by defining specific peptide domains of proSP-C necessary for translocation and for targeting to processing compartments. Domain-specific proSP-C deletional mutants were used to construct and transfect heterologous fusion proteins containing the enhanced green fluorescent protein (EGFP) into the previously described A549 epithelial cell model and the neuroendocrine cell line PC-12, which has been shown to contain a regulated secretory pathway for exocytosis (14) . The results of this study now demonstrate that a functional, internal signal sequence contained within the mature SP-C domain is sufficient for translocation of EGFP/SP-C into the ER in A549 and PC-12 cells. In addition, we also show that the region Met 10 to Gln 23 , contained within the NH 2 flanking region, is necessary for targeting of translocated proSP-C from proximal compartments to more distal sites. The presence of the distal portion of the COOH-terminal flanking domain, shown in the previous study (8) to be necessary for processing, was not sufficient for targeting alone or when coupled with the signal peptide domain of proSP-C.
EXPERIMENTAL PROCEDURES

Materials
The pcDNA3 eukaryotic expression plasmid was obtained from Invitrogen (San Diego, CA). pEGFP-C 1 and pEGFP-N 1 plasmids and polyclonal anti-green fluorescent protein (GFP) antisera were purchased from Clontech (Palo Alto, CA).
N-((4,4-difluoro-5-(2-thienyl)-4-bora-3a,4a-diaza-s-indacene-
3-yl)phenoxyl)acetyl)sphingosine-Texas red (BODIPY TR ceramide) and LysoTracker blue were purchased from Molecular Probes (Eugene, OR). LipofectAMINE was obtained from Life Technologies (Gaithersburg, MD). Except where noted, other reagents were of electrophoretic grade and were purchased from Bio-Rad (Melville, NY) or Sigma (St. Louis, MO).
ProSP-C antiserum. Monospecific polyclonal rat proSP-C antisera were produced from a synthetic peptide immunogen and have been previously characterized (7) . Anti-NPROSP-C (Met 10 to Glu 23 ) recognizes proSP-C 21 and all major intermediates but does not recognize mature SP-C.
SP-C cDNA Expression Constructs
All procedures involving oligonucleotide and cDNA manipulations were performed essentially as described by Ausbel et al. (2) .
pcDNA3-rSP-C(ϩ).
A full-length rat SP-C cDNA (816 bp) insert was previously subcloned into the pcDNA3 eukaryotic expression vector polylinker at the EcoR I site (12) . The vector contains the human cytomegalovirus promoter (early promoter and enhancer region), bovine growth hormone polyadenylation sequence, ␤-lactamase and neomycin resistance genes, and T7 and SP6 promoters for sense/antisense in vitro transcription. Detailed characterization of pcDNA3-rSP-C(ϩ) has been previously published (8) .
Chimeric EGFP fusion proteins. A family of chimeric fusion proteins consisting of EGFP and wild-type rat SP-C (Met 1 to Ile 194 ) or mutant SP-C cDNA containing truncations of the COOH-and/or NH 2 -terminal flanking region of proSP-C generated by PCR are schematically illustrated in Fig. 1 . In all cases, pcDNA3-rSP-C(ϩ) was used as a template. Sequences encoding the indicated regions of proSP-C peptide were amplified by PCR with use of modified primers to create in-frame fusion proteins through introduction of 1) a BspE I site at the 5Ј-end and an Xho I site at the 3Ј-end for cloning into pEGFP-C 1 (Fig. 1A) or 2) a Kpn I site at the 5Ј-end and an Age I site at the 3Ј-end for cloning into pEGFP-N 1 (Fig. 1B) . The oligonucleotide primers are listed in Table 1 .
Amplification reactions containing 0.2 µM primers, 1.25 µM dNTP mixture, 1.5 µM MgCl 2 , 10 ng of template, and 2.5 U of Vent DNA polymerase (New England Biolabs, Beverly, MA) consisted of 30 cycles as follows: denaturation at 95°C for 30 s, primer annealing at 60°C for 30 s, and primer extension at 72°C for 15 s. After the last cycle, the mixture was incubated at 72°C for 7 min. Purified PCR fragments were ligated into pEGFP-C 1 after digestion with BspE I and Xho I or into pEGFP-N 1 after digestion with Kpn I and Age I.
For construction of EGFP/SP-C ⌬60-175 (Fig. 1C) , deletion mutagenesis was performed by overlap extension PCR with a two-round, four-primer technique (11) . In round 1, two PCR products (SP-C 1-59X and SP-C Y176-194 ) were generated in separate reactions carried out using pcDNA3-rSP-C(ϩ) as the template with primers A and B or primers C and D (Table 2) . Cycling conditions for round 1 were as follows: one cycle at 94°C for 1 min 30 s, 25 cycles at 94°C for 40 s, 50°C for 30 s, and 72°C for 40 s, and a final extension at 72°C for 7 min. The resulting products were purified using the Wizard PCR Prep DNA Purification System (Promega, Madison, WI). Purified segments SP-C 1-59X and SP-C Y176-194 were added jointly along with primers A and D for round 2 of PCR. Fusion of the two intermediate segments is achieved as a result of overlapping complementary regions in the products produced in round 1, which pair during the annealing phase of PCR round 2 and are amplified by use of primers complementary to the 5Ј-and 3Ј-ends ( primers A and D, respectively). Cycling conditions in round 2 were identical to those in round 1 described above. The resulting mutant insert, SP-C ⌬60-175 , was purified and ligated into pEGFP-C 1 after digestion with BspE I and Xho I.
Automated DNA sequencing in both directions was performed at the Core Facility in the Department of Genetics at the University of Pennsylvania. No nucleotide mutations in the coding region of full-length SP-C or any deletional con-structs were detected with the exception of EGFP/SP-C 1-72 (D2Q).
Cell Lines and Transfection
A549 cells. The lung epithelial cell line A549 utilized in transfection studies was originally obtained through the American Type Culture Collection (Manassas, VA) and made available as a gift of Dr. S. I. Feinstein. A549 cells were grown at 37°C in 5% CO 2 in DMEM supplemented with 10% FCS, 100 U/ml penicillin, and 100 µg/ml streptomycin, as previously described (8) .
For transfection studies, A549 cells were grown to 80% confluence in 35-mm 2 plates (Corning). EGFP/SP-C constructs (10 µg/dish) were transiently transfected into A549 cells by CaPO 4 precipitation: 0.18 ml of 0.25 M CaCl 2 was added dropwise to 0.18 ml of plasmid DNA dissolved in 2ϫ HEPES-buffered saline (50 mM HEPES, 280 mM NaCl, and 1.5 mM NaPO 4 , pH 7.1) (2). The medium was replaced at 24 h, and cells were maintained for up to 48 h.
PC-12 cells. PC-12 cells (rat pheochromocytoma cells, clone 251), a gift from Dr. Harry Ischiropoulos (University of Pennsylvania), were grown in 75-cm 2 culture flasks containing RPMI 1640 supplemented with 10% horse serum and 5% fetal bovine serum, 100 U/ml penicillin, and 100 µg/ml streptomycin at 37°C in 5% CO 2 . Under these conditions, PC-12 cells are not dependent on nerve growth factor for survival.
For transfection, PC-12 cells were grown to 60% confluence in 35-mm 2 plates; 20 µg of plasmid DNA were combined with 10 µl of LipofectAMINE and applied to cells in Optimem 
Fluorescence Microscopy
Vital fluorescence microscopy for localization of expressed EGFP/SP-C fusion proteins was performed on 35-mm 2 plastic dishes with an Olympus I-70 inverted fluorescence microscope with filter packages High Q fluorescein isothiocyanate for GFP (excitation at 480 nm, emission at 535/550 nm), High Q TR for Texas red (excitation at 560/555 nm, emission at 645/675 nm), and standard 4,6-diamidino-2-phenylindole for LysoTracker blue (excitation at 360/340 nm, emission at 460 nm) obtained from Chroma Technology (Brattleboro, VT). Fluorescent and phase images were captured using a Hamamatsu 12-bit coupled-charge device camera. Image processing and overlay analysis were performed using IMAGE 1 software (Universal Imaging, West Chester, PA).
Analytic Methods
PAGE and immunoblotting.
One-dimensional SDS-PAGE was performed in 12% polyacrylamide gels by the method of Laemmli (20) . Proteins were transferred to nitrocellulose, and immunoblotting of transferred samples was performed as previously described (5) using primary polyclonal anti-GFP antiserum (1:2,000). Bands were visualized by enhanced chemiluminescence (ECL kit, Amersham, Arlington Heights, IL).
RESULTS
Expression of EGFP/SP-C 1-194 Protein by Transfected A549 Cells
Expression of EGFP-C 1 and EGFP-C 1 /SP-C 1-194 fusion proteins was readily detected in transiently transfected A549 cells within 24-48 h after introduction of plasmids by CaPO 4 -DNA precipitation. In Fig. 2A , Table 1 
. Primer sets used in PCRs for generation of EGFP rat SP-C fusion constructs
Construct Name
Rat SP-C Amino Acid PCR Primers 5Ј Primer (forward) 3Ј Primer (reverse)
Met 1 -His 72 dTACAAGTCCGGAATGGACATGGGTAGCAAAGAG dCCCTCGAGTGTTAGCTCATCTCAAGGACCA EGFP-C 1 /SP-C Met 1 -Leu 175 dTACAAGTCCGGAATGGACATGGGTAGCAAAGAG dCCCTCGAGTGTTACAGGTCTCGCCCAGAAG EGFP-C 1 /SP-C Met 1 -Leu 185 dTACAAGTCCGGAATGGACATGGGTAGCAAAGAG dCCCTCGAGTGTTACAAGGTGCTCACAGCAA EGFP-C 1 /SP-C Met 1 -Ile 194 dTACAAGTCCGGAATGGACATGGGTAGCAAAGAG dTCTAGATGCATGCTCGAGCG EGFP-C 1 /SP-C Met 10 -Ile 194 dTACAAGTCCGGAATGGAGAGCCCACCGGATTAC dTCTAGATGCATGCTCGAGCG EGFP-C 1 /SP-C Phe 24 -His 59 dTACAAGTCCGGATTTCGCATTCCCTGCTGC dCCCTCGAGTGTTAGTGAAGGCCCATGAGCA EGFP-C 1 /SP-C Phe 24 Amino acid numbers correspond to nucleic acids in rat surfactant protein C (SP-C) cDNA (Ref. 12) . In all cases, pcDNA3-rSP-C(ϩ) (Ref. 12) was used as template. For enhanced green fluorescent protein (EGFP)-C 1 , each 5Ј primer contains a BspE I site (5Ј-TCCGGA-3Ј) for in-frame ligation; for constructs containing COOH-terminal truncations, 3Ј primer contains an Xho I site (5Ј-CTCGAG-3Ј) for ligation into EGFP-C 1 polylinker and TTA for production of a stop codon immediately adjacent to terminal codon of truncated coding sequence; for constructs containing Ile 194 , 3Ј primer matches polylinker of pcDNA3 and contains an Xho I site (use of this primer resulted in inclusion of 3Ј-untranslated region in these constructs). For EGFP-N 1 , each 3Ј primer contains an Age I site (5Ј-ACCGGT-3Ј) for in-frame cloning into EGFP-N 1 ; for SP-C 1-59 , 5Ј primer corresponds to polylinker sequence of pcDNA3 with Kpn I site (GGTACC) included; for SP-C 24-59 , 5Ј primer contains a Kpn I site (GGTACC), start codon (ATG), and Kozak sequence. Primary PCR
For both reactions of primary PCR, pcDNA3-rSP-C(ϩ) (Ref. http://ajplung.physiology.org/ transfection of EGFP-C 1 resulted in expression of a fluorescent signal in a diffuse pattern throughout the cell. In contrast, EGFP-C 1 /SP-C was expressed in a similar time frame but was spatially restricted to cytoplasmic vesicles of A549 cells (Fig. 2B ). This pattern was similar to that seen with A549 cells transfected with wild-type proSP-C (pcDNA3-rSP-C wt ), fixed, and stained with anti-NPROSP-C antiserum (Fig. 2C) . These results indicate that the presence of EGFP does not interfere with proSP-C trafficking and that SP-C contains motifs for ER translocation (signal peptide) and direction of a heterologous fusion protein (EGFP) into distal vesicular compartments.
To define the major forms of transfected EGFP/ proSP-C fusion proteins expressed, Western blotting was performed using a polyclonal anti-GFP antibody (Fig. 3) . Transfection of A549 cells with EGFP resulted in expression of a major product matching the predicted relative molecular weight (M r ) of 27,000 (Fig. 3, lane 2) . A minor band migrating at M r 33,000 but constituting Ͻ10% of the total signal also appeared ( * ). Neither band was detected in cell lysates of mock-transfected cells, demonstrating specificity of the antiserum (lane 3). When EGFP-C 1 /SP-C was transfected, three bands were detected (Fig. 3, lane 1) . A band with M r 48,000, representing the predicted M r of the primary translation product of the fusion protein, and two major intermediate forms of M r 42,000 and 32,500 were identified (arrowheads). Bands with M r 27,000-32,500 were not found, indicating that EGFP-C 1 /SP-C was partially processed by complete removal of the proSP-C COOH terminus.
To further characterize the compartment in A549 cells to which EGFP-C 1 /SP-C 1-194 fusion protein was being directed, fluorescence microscopy of transfected EGFP-C 1 /SP-C was performed in combination with markers for acidic compartments (Fig. 4) . The EGFP-C 1 /SP-C fluorescent fusion protein could be colocalized with the LysoTracker blue probe, a fluorescence marker that accumulates in acidic subcellular compartments (Fig. 4) . Thus EGFP-C 1 /SP-C 1-194 is expressed and targeted to acidic cytoplasmic vesicles of A549 cells.
Mature SP-C Molecule Contains a Functional Signal Sequence
We had hypothesized that mature SP-C peptide functions as a signal sequence. Fusion proteins containing EGFP and mature SP-C molecule (Phe 24 to Ile 58 ) were tested for their ability to direct translated protein from the cytoplasm to the ER (Fig. 5) . EGFP-C 1 /SP-C , in which the mature sequence was inserted at the COOH terminus of EGFP, was capable of mediating the translocation of GFP. Fluorescence micrographs show distribution of EGFP-C 1 /SP-C 24-59 in a juxtanuclear compartment (Fig. 5B) . Mature SP-C could also function as a signal sequence when placed in an NH 2 - Fig. 2 . Expression of EGFP, EGFP-C 1 /SP-C , and wild-type proSP-C [pcDNA3-rSP-C(ϩ)] in transfected A549 cells. Forty-eight hours after introduction of plasmid DNA, A549 cells transfected with EGFP-C 1 (A) or EGFP-C 1 /SP-C (B) were directly examined by fluorescence microscopy with a High Q fluorescein isothiocyanate (FITC) filter package for GFP (excitation at 480 nm, emission at 535/550 nm). Distribution of EGFP-C 1 /SP-C was then compared with distribution of native wild-type rat proSP-C (pcDNA3-rSP-C wt , C), in which A549 cells transfected with pcDNA3-rSP-C(ϩ) were fixed and stained with primary anti-NPROSP-C (NPROSP-C, 1:200) and secondary goat anti-rabbit IgG Texas red (TR), and fluorescence images were acquired using a High Q TR filter package (excitation at 560/555 nm, emission at 645/675 nm). N, nucleus. . After 48 h of transfection, cells were harvested by scraping and centrifugation for 10 min at 300 g. Nuclear-free lysates were prepared from cell pellet by incubation with 50 µl of PBS containing 1% Triton X-100 and protease inhibitors, then centrifuged for 30 s at 12,000 g to remove nuclei. Fifty percent of each nuclear-free lysate was subjected to 12% SDS-PAGE. Separated proteins were transferred to nitrocellulose and immunoblotted with primary rabbit polyclonal anti-GFP (Clontech, Palo Alto, CA). Bands were visualized using enhanced chemiluminescence (Amersham). Analysis of EGFP-C 1 /SP-C fusion protein expression demonstrated 3 bands with relative molecular weight (M r ) of 48,000, 42,000, and 33,000 (lane 1). EGFP-C 1 was expressed as a major product with M r 27,000 (lane 2) with a minor form at 32,500 ( * ). terminal position. SP-C 24-59 /EGFP-N 1 , a construct containing mature SP-C in frame with the NH 2 terminus of EGFP, was expressed in a pattern identical to EGFP-C 1 / SP-C (Fig. 5C) .
Role of the COOH Flanking Peptide
To investigate the role of the COOH flanking peptide in the targeting proSP-C, EGFP fusion proteins containing truncations of the distal proSP-C COOH terminus were constructed and transfected into A549 cells (Figs.  6 and 7) . In contrast to fusion proteins containing wild-type SP-C (Fig. 6A) , expression of these two mutants was restricted to more proximal compartments. Expression of EGFP-C 1 /SP-C (Fig. 6B) and EGFP-C 1 /SP-C (Figs. 6C and 7B ) was limited to early compartments. With use of BODIPY TR ceramide to identify ER / Golgi compartments in A549 cells (Fig. 7) , fluorescence overlays demonstrated colocalization of EGFP-C 1 /SP-C 1-185 with ceramide-labeled compartments (Fig. 7D) .
In contrast to removal of the distal COOH terminus, more extensive truncation of the COOH domain restored targeting. When EGFP-C 1 /SP-C 1-72 was transfected, localization of the fusion product to cytoplasmic vesicles was observed (Fig. 6E) . To determine whether the domain His 59 to Ser 72 contained a specific motif, an additional construct was created in which His 59 to Ser 72 was replaced with the distal COOH terminus. The resulting construct, EGFP-C 1 /SP-C ⌬60-175 , also appeared in cytoplasmic vesicles (Fig. 6F) . As expected, transient transfections of EGFP and the distal COOH terminus alone (EGFP-C 1 /SP-C [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] ) produced an expression pattern similar to EGFP-C 1 (Fig. 6D ). This pattern of diffuse fluorescence appearing throughout transfected A549 cells was recapitulated with the use of EGFP-C 1 /SP-C 185-194 (data not shown). Taken together, these results indicate that the COOH flanking peptide of proSP-C does not contain specific targeting motifs for delivery to cytoplasmic vesicles. 
Met 10 to Gln 23 Is Required for ProSP-C Targeting
We next evaluated domains of the NH 2 terminus for the presence of targeting motifs. Deletion of the entire NH 2 flanking domain resulted in limitation of expression of the truncated fusion protein to early compartments (Fig. 8A) . As with EGFP-C 1 /SP-C 175-194 , the deleted region Met 1 to Gln 23 alone was incapable of translocation or targeting of EGFP (Fig. 8B) . Importantly, when Met 10 to Gln 23 was reconstituted with EGFP-C 1 /SP-C , the resulting construct, EGFP-C 1 / SP-C , was directed to cytoplasmic vesicles (Fig.  8C) , indicating that this region contained a cytoplasmic targeting motif.
Targeting of EGFP/SP-C Fusion Proteins in Neuroendocrine Cells
To determine whether the targeting epitopes in the proSP-C molecule are recognized by sorting machinery of nonlung epithelial cells, the neuroendocrine cell line PC-12 was transfected with EGFP-SP-C fusion proteins (Fig. 9) . As for A549 cells, EGFP alone was expressed diffusely throughout the cytoplasm of PC-12 cells (not shown). In contrast, EGFP-C 1 /SP-C was directed to vesicles throughout the cytoplasm, in neurites, and beneath the plasma membrane (Fig. 9, A and  AЈ) . The mature SP-C sequence was capable of effecting translocation into ER /Golgi compartments but was insufficient for direction of fusion proteins to more distal compartments in the secretory pathway (Fig. 9, B and BЈ). Similar to A549 cells, the deletion of the NH 2 flanking domain of proSP-C resulted in retention in early compartments (Fig. 9, C and CЈ) .
DISCUSSION
The complete synthesis of SP-C by the alveolar type II cell must include translation and translocation of proSP-C to the ER, palmitoylation, sorting, and exit of the proprotein from the Golgi compartment, cleavage of flanking propeptide domains, and assembly of mature SP-C with surfactant phospholipids and SP-B in the http://ajplung.physiology.org/ Downloaded from lamellar body followed by exocytosis (6) . Comparative analysis of numerous secreted proteins has failed to identify consistently conserved amino acid sequences that mediate translocation of the primary translation product or selective targeting to secretory granules. Although by deletional analysis and construction of fusion proteins, functional targeting determinants have been localized for several secretory proteins, including SP-B (1, 21, 22) , such detailed information regarding SP-C has been lacking. Previously, we showed that synthetic processing of SP-C by alveolar epithelial cells was dependent, in part, on an intact distal COOH propeptide terminus (8) . The present study extends these observations by use of alveolar epithelial and neuroendocrine cell lines to define sequence motifs important for correct translocation and targeting. We have now identified two functional domains in the primary sequence that are responsible for the normal trafficking of synthesized proSP-C protein. The mature SP-C sequence has been shown to function as a noncleavable signal peptide, whereas the direction of EGFP fusion proteins to cytoplasmic targets is dependent on the presence of the region Met 10 to Gln 23 found in the NH 2 -terminal flanking domain. In addition, although disruption of the distal COOH terminus results in mistargeting, the COOH-terminal flanking region does not appear to contain targeting motifs.
Transfection of a plasmid containing EGFP alone into A549 cells resulted in expression of fluorescent protein in a diffuse pattern throughout the entire cell, consistent with and predicted by the lack of a signal peptide in the EGFP sequence. The fusion protein consisting of full-length proSP-C in frame with EGFP was capable of ER translocation and targeting, as indicated by the resulting vesicular fluorescence pattern (Figs. 2, 4, 6, and 7) . The pattern of EGFP/SP-C expression seen in vital fluorescence microscopy was http://ajplung.physiology.org/ similar to immunocytochemical staining patterns of fixed A549 cells transfected with SP-C , indicating that EGFP does not affect the targeting of proSP-C (Fig. 2B) (8) . Previously, in isolated rat type II cells, we demonstrated that endogenous proSP-C was targeted to acidic compartments distal to the Golgi compartment (4) . Colocalization studies with the LysoTracker blue marker indicated that the vesicles in A549 cells (Fig. 4) were also acidic. As for primary type II cells, delivery of proSP-C (EGFP/SP-C ) to acidic cytosolic vesicles in A549 cells is associated with posttranslational proteolytic processing of proSP-C. Using metabolic labeling, we previously demonstrated synthesis of proSP-C 21 and cleavage to proSP-C 16 and proSP-C 6 intermediates by transfected A549 cells, but the lack of a monospecific antibody against the mature SP-C epitope prevented us from definitively detecting the presence of mature SP-C (8). In the present study, the appearance of EGFP/SP-C in cytosolic vesicles is associated with processing of the fusion protein, as indicated by Western blotting patterns (Fig. 3) . The banding pattern of cell lysates from transfections of EGFP/SP-C is consistent with complete cleavage of the COOH flanking sequence. However, the failure to liberate free EGFP (M r 27,000) or a product of M r 29,000 (EGFP ϩ proSP-C NH 2 terminus) indicates that these cells do not fully process the NH 2 terminus of proSP-C, leaving a truncated fusion protein of EGFP/ SP-C 6 .
Although the A549 cell line was originally derived from alveolar type II cells, the failure to fully process proSP-C may be due to limitations with this model. In contrast to type II cells, the A549 cell, as well as any available cell line model, does have potential limitations in attempting to mimic all functional aspects of surfactant metabolism. For A549 cells, these limitations include a lack of lamellar bodies, a lack of SP expression, and a lack of a stimulated (regulated) secretory pathway. Because in type II cell and perfused lung models final processing (NH 2 -terminal proteolysis) has been shown to occur at or near the lamellar body, we speculate that the lack of lamellar bodies in A549 cells (which also do not express SP-B) may contribute to the failure to completely process the NH 2 terminus of proSP-C. Nonetheless, this model does appear useful in evaluating important early events, namely, translocation and targeting from the Golgi compartment, but may not be as useful in evaluating later secretory events. A recent preliminary report by Conkright et al. (9) has shown that primary isolated mouse type II cells can maintain a type II cell phenotype in culture. If transfectable with reasonable efficiency, this cell model may be of use in future studies.
Because of the potential limitations in relying on a single model, we chose to evaluate some of the findings in the neuroendocrine cell line PC-12. Although these cells have a regulated secretory pathway that has been shown to target transfected SP-B constructs (21), they do not process surfactant proprotein, do not synthesize or store phospholipid, and, in cases of overexpression of transfected protein, will target to a constitutive pathway. Importantly, we have found that the ability of specific motifs in proSP-C to target EGFP/SP-C in A549 cells could be recapitulated using PC-12 cells. The location of fusion proteins in cytosolic vesicles in neurite structures is consistent with targeting to the regulated pathway, although alternative direction of fusions to constitutive vesicles or lysosomes cannot be excluded from the present studies. With use of the LysoTracker reagent, acidic vesicles can be identified in similar locations within the neurites of PC-12 cells; this is consistent with the known pH of secretory granules (unpublished observations). Thus our approach has been to examine targeting in two separate but complementary models, and, taken together, results shown here support the notion that proSP-C signal and sorting domains are functional in epithelial and endocrine cells.
In contrast to SP-B, proSP-C does not contain a consensus sequence for a cleavable signal peptide (12) . Deletional analysis mapped the functional signal sequence to amino acids 24-59, the sequence of the mature SP-C molecule, which was capable of inducing translocation of EGFP in A549 and PC-12 cells. From in vitro studies, proSP-C has been shown to be an integral membrane protein (27) , with the mature SP-C sequence postulated to act as a membrane anchor (18) . It now appears that this region is also required for ER translocation and that this function is independent of its position within the fusion protein. EGFP-C 1 and EGFP-N 1 plasmids each containing mature SP-C alone could be translocated, indicating that the mature SP-C sequence can function as a signal sequence regardless of placement in an NH 2 -terminal position (SP-C 24-59 / EGFP-N 1 ), COOH-terminal position (EGFP-C 1 /SP-C 24-59 ), or internal position (EGFP-C 1 /SP-C ).
Interestingly, the expression pattern of EGFP-C 1 /SP-C and SP-C 24-59 /EGFP-N 1 shows clustering of mutant fusion protein in juxtanuclear structures of A549 (Fig. 5 ) and PC-12 (Fig. 9B) cells. The appearance of a localized ''hot spot'' image is consistent with a similar structure previously described by Johnston et al. (17) using HEK-293 cells stably transfected with a mutant form of another integral membrane protein, cystic fibrosis transmembrane regulator (CFTR). Overexpression of the ⌬F508 form of CFTR or inhibition of cellular proteasome activity in transfected cells led to the accumulation of stable, aggregated, high-molecularweight, detergent-insoluble, multiubiquinated forms of CFTR. Immunofluorescence demonstrated accumulation of undegraded CFTR in a distinct pericentriolar structure, which they have termed the aggresome. Thus it appears that the EGFP/SP-C and SP-C 24-59 / EGFP are translocated but end up in juxtanuclear structures that are compatible with aggresomes. As for CFTR or any other aggregation-prone protein, this could occur if the high-level expression of these mutants is misfolded and/or aggregated and the levels of abnormal protein exceed the capacity of the proteasome.
Despite being necessary and sufficient for translocation, the mature SP-C molecule was incapable of direct- http://ajplung.physiology.org/ ing fusion proteins to distal (cytoplasmic) compartments. Previously, data from our group and others (8, 19) demonstrated the importance of an intact COOH propeptide terminus for targeting and processing. Keller et al. (19) showed that deletion of 22 amino acids from the COOH terminus resulted in retention of mutant proSP-C protein within the ER of Chinese hamster ovary cells. We previously extended this observation by demonstrating that deletion of as few as 10 amino acids of this COOH terminus resulted in colocalization of the mutated protein with a concanavlin A-stained (ER / Golgi) compartment in A549 cells (8) . In this study, we asked whether the distal COOH terminus could act as a sorting signal. EGFP fusion proteins containing only the domain Leu 175 to Ile 194 were not targeted (Fig. 6) , which again is attributable to the absence of a signal peptide sequence. However, even if the entire COOH propeptide domain (His 59 to Ile 194 ) was combined with the mature SP-C molecule (EGFP-C 1 /SP-C ), expression was limited to early compartments. In combination with studies using EGFP-C 1 /SP-C ⌬60-175 and EGFP-C 1 /SP-C 1-72 , which were targeted to cytoplasmic vesicles (Fig. 6 ), these results demonstrate that the COOH flanking domain (His 59 to Leu 72 , Leu 60 to Leu 175 , and Leu 175 to Ile 194 ) does not contain regions that are sufficient alone or in the context of the signal peptide to target proSP-C. In this regard, proSP-C trafficking appears to be similar to SP-B, in which deletion analysis has shown that the NH 2 flanking domain and mature peptide are sufficient to effect targeting (1) . Although the COOH domain of SP-B appears to play a role in the genesis of the lamellar body, the function of the proSP-C COOH flanking sequence remains to be defined.
Although significantly shorter than the COOH flanking peptide, the NH 2 -terminal domain of proSP-C is highly conserved among all species (12) . The lack of vesicular targeting of EGFP fusions containing NH 2 -terminal deletions (SP-C and SP-C ) is consistent with removal of targeting determinants. The restoration of targeting with the use of EGFP-C 1 /SP-C identifies the region Met 10 to Gln 23 as the targeting sequence. Although proSP-C is targeted to acidic vesicles in type II and A549 cells and the lamellar body has been shown to contain lysosomal markers such as LAMP-1 (lgp-120) (32), there is no homology of this region with other known lysosomal targeting determinants such as dileucine-or tyrosine-based motifs found in other integral bitopic membrane proteins such as LAMP-1 or CD-3␥. BLAST search of the domain Met 10 to Gln 23 has failed to identify homology with other known domains and underscores the novelty of this motif.
Although the amino flanking sequence contains the targeting motif, the restriction to ER /Golgi compartments observed from the deletion of the distal COOH terminus is probably due to another mechanism. Misfolding of the natural conformation of proteins has been associated with aggregation and retention in the early stages of the secretory pathway (15) . Within the COOH terminus of proSP-C, two conserved cysteine residues (C 122 and C 186 ) could promote intrachain folding. Generation of EGFP-C 1 /SP-C 1-175 and EGFP-C 1 /SP-C 1-185 mutants results in deletion of one of these residues (C 186 ). Thus misfolding of nascent protein could serve as the mechanism for retention of distal COOH truncations in more proximal compartments. Additional studies utilizing site-directed mutagenesis of C 120 and C 186 are in progress to further define the role of the cysteines in the COOH-terminal flanking peptide.
The SP-C molecule is unique, in that the primary translation product and the processed, secreted, mature SP-C peptide represent bitopic transmembrane proteins. Because of the extreme hydrophobicity of the mature SP-C molecule, it is likely that the successful export of proSP-C from early (ER and Golgi) compartments is dependent on proper ER membrane insertion (orientation), conformational folding, and exposure of targeting motifs. On the basis of our results in this study and previous work by our group and others (7, 8, 19, (27) (28) (29) , we can propose a model for the role of the proSP-C peptide domains: during translation, the proSP-C primary translation product is translocated to the ER and inserted into the ER membrane as an integral membrane protein in a type II membrane orientation (NH 2 in cytoplasm) that is mediated by the domain SP-C . After membrane insertion, disulfidemediated folding of the COOH terminus can occur in the oxidizing environment of the ER lumen. It is likely that membrane insertion and protein folding expose the targeting motif within the NH 2 flanking sequence (Met 10 to Gln 23 ) that subsequently facilitates exit from the Golgi compartment via transport vesicles. Still membrane associated, the propeptide is remodeled by proteolytic cleavage of initially COOH, then NH 2 , domains during transport to multivesicular bodies and subsequent transfer to lamellar bodies. Although this model assumes that SP-C is a type II bitopic membrane protein, the exact orientation of proSP-C in intracellular membranes is unclear. By utilizing modeling studies of other bitopic transmembrane proteins, on the basis of charge differences on either side of the transmembrane ␣-helix (window ϭ 15 residues; C-N ϭ Ϫ1), the NH 2 terminus of proSP-C is predicted to be within the cytoplasm (16) . This prediction has been supported by an in vitro study that used protease protection assays in model vesicular systems (18) . However, using slightly different methodology, another group has found a type III orientation (COOH in the cytoplasm) (29) . Therefore, additional studies using in situ techniques will likely be required, and the determination of precise orientation of proSP-C will also promote further targeting studies that can test the ability of the NH 2 flanking sequence (Met 10 to Gln 23 ) for the targeting of other heterologous transmembrane protein segments.
In conclusion, SP-C, like SP-B, is expressed as a larger proprotein that undergoes extensive posttranslational processing before it achieves a mature, functional form. Although both proteins contain motifs critical for proper folding and appear to rely on NH 2 flanking domains to effect targeting to the secretory pathway of type II cells, our results with heterologous fusion proteins demonstrate that SP-C differs from SP-B, in that it contains a noncleavable internal signal peptide sequence (mature SP-C). Furthermore, although complete processing appears to be cell specific, recognition of the proSP-C targeting motifs appears to be ubiquitous, inasmuch as a neuroendocrine cell line and an alveolar epithelial cell line are capable of recognizing these domains for the direction of fusion proteins.
